Table 1.
The data of selected clinical isolates reported by GCC countries
| Country | Population | Population % | Reports (n) | Reports% | Isolates (n) | Isolates% | References |
|---|---|---|---|---|---|---|---|
| Bahrain |
1,106,509 |
2.9% |
3 |
9.1% |
2841 |
7.6% |
[4-6] |
| Kuwait |
2,583,020 |
6.7% |
9 |
27.3% |
20339 |
54.5% |
[7-15] |
| Oman |
3,173,917 |
8.2% |
3 |
9.1% |
882 |
2.4% |
[8,16,17] |
| Qatar |
1,608,903 |
4.2% |
2 |
6.1% |
570 |
1.5% |
[7,18] |
| Saudi Arabia |
25,373,512 |
65.7% |
14 |
42.4% |
12174 |
32.6% |
[19-32] |
| UAE |
4,765,000 |
12.3% |
2 |
6.1% |
491 |
1.3% |
[33,34] |
| GCC total | 38,610,861 | 100.0% | 33 | 100.0% | 37295 | 100.0% | n = 33 articles |
GCC = Gulf Corporation Council; UAE = United Arab Emirates.